A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

Clinical trial NCT03812263 · COMPLETED

Trial details

NCT number: NCT03812263
Sponsor: Rocket Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukocyte Adhesion Defect - Type I

Start date: 2019-08-30
Primary completion: 2023-09-12
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.